CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Heavy Buying Penny Stock Under Rs 5; Hit 10 Per Cent Upper Circuit On October 16 On Positive Results For Q2FY25 & H1FY25
DSIJ Intelligence-1
/ Categories: Trending, Penny Stocks

Heavy Buying Penny Stock Under Rs 5; Hit 10 Per Cent Upper Circuit On October 16 On Positive Results For Q2FY25 & H1FY25

The shares of the company saw a spurt in volume by more than 2.75 times on BSE.

On Wednesday, shares of Rajnish Wellness Limited hit a 10 per cent upper circuit to Rs 3.31 per share from its previous closing of Rs 3.01. The stock’s 52-week high is Rs 14.69 and its 52-week low is Rs 2.82. The company has a market cap of over Rs 250 crore. The shares of the company saw a spurt in volume by more than 2.75 times on BSE.

The sudden rise in the stock price was due to the company announcing positive Quarterly Results (Q2FY25) and half-yearly results (H1FY25). Here are the details: -

According to quarterly results, the company reported net sales of Rs 17.42 crore and net profit of Rs 0.28 crore in Q2FY25 compared to net sales of Rs 18.51 crore and net profit of Rs 0.10 crore in Q2FY24. In its half-yearly results, the company reported net sales of Rs 33.72 crore and net profit of Rs 0.45 crore in H1FY25 compared to net sales of Rs 27.02 crore and net profit of Rs 0.65 crore in H1FY24.

Rajnish Wellness Ltd is making a significant stride in expanding its retail presence in India. The company's strategic decision to open 20 new Dava Discount outlets in key cities is a testament to its commitment to enhancing accessibility to affordable healthcare products. This expansion is expected to generate substantial revenue, with each outlet projected to earn between Rs 15 million and Rs 20 million annually.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

Furthermore, Rajnish Wellness has secured a contract with Indian Railways to establish 270 Dava Discount stores in West Bengal, further solidifying its position as a leading player in the healthcare market. By offering a wide range of affordable medicines and in-house products, Rajnish Wellness is catering to the growing demand for wellness and healthcare solutions. The company's focus on high-demand areas with significant healthcare sales potential ensures that its products reach the people who need them most. With these expansions, Rajnish Wellness is not only strengthening its market presence but also making a positive impact on the lives of millions of people across India.

Rajnish Wellness Ltd., established in 2015, is a prominent player in the Indian healthcare market, specializing in sexual wellness, energy revitalization, and personal care products. With its flagship brand "PlayWin," the company has gained significant traction in the sexual wellness category. Rajnish Wellness offers a comprehensive range of products, including contraceptives, sexual enhancement supplements, personal lubricants, and personal and healthcare products, available under various brand names such as PlayWin, Rajnish, and Madamrit. The company's strong geographical presence across India, particularly in key states like Maharashtra, Uttar Pradesh, Karnataka, and Bihar, ensures widespread accessibility to its products through a vast network of medical stores.

Disclaimer: The article is for informational purposes only and not investment advice. 

Previous Article Rs 4,909 Billion Order Book: LIC-Backed Civil Construction Company Bags Approx. Rs 2,500 Crore Order For Agra Metro Network
Next Article October 17 Pre-Market: Flat to Positive Start Expected as Key Stocks Face F&O Ban—What You Need to Know
Print
1027 Rate this article:
4.1
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR